Causes and prevalence of visual impairment among adults in the United States - PubMed (original) (raw)
Comparative Study
. 2004 Apr;122(4):477-85.
doi: 10.1001/archopht.122.4.477.
Affiliations
- PMID: 15078664
- DOI: 10.1001/archopht.122.4.477
Comparative Study
Causes and prevalence of visual impairment among adults in the United States
Nathan Congdon et al. Arch Ophthalmol. 2004 Apr.
Abstract
Objectives: To estimate the cause-specific prevalence and distribution of blindness and low vision in the United States by age, race/ethnicity, and gender, and to estimate the change in these prevalence figures over the next 20 years.
Methods: Summary prevalence estimates of blindness (both according to the US definition of < or =6/60 [< or =20/200] best-corrected visual acuity in the better-seeing eye and the World Health Organization standard of < 6/120 [< 20/400]) and low vision (< 6/12 [< 20/40] best-corrected vision in the better-seeing eye) were prepared separately for black, Hispanic, and white persons in 5-year age intervals starting at 40 years. The estimated prevalences were based on recent population-based studies in the United States, Australia, and Europe. These estimates were applied to 2000 US Census data, and to projected US population figures for 2020, to estimate the number of Americans with visual impairment. Cause-specific prevalences of blindness and low vision were also estimated for the different racial/ethnic groups.
Results: Based on demographics from the 2000 US Census, an estimated 937 000 (0.78%) Americans older than 40 years were blind (US definition). An additional 2.4 million Americans (1.98%) had low vision. The leading cause of blindness among white persons was age-related macular degeneration (54.4% of the cases), while among black persons, cataract and glaucoma accounted for more than 60% of blindness. Cataract was the leading cause of low vision, responsible for approximately 50% of bilateral vision worse than 6/12 (20/40) among white, black, and Hispanic persons. The number of blind persons in the US is projected to increase by 70% to 1.6 million by 2020, with a similar rise projected for low vision.
Conclusions: Blindness or low vision affects approximately 1 in 28 Americans older than 40 years. The specific causes of visual impairment, and especially blindness, vary greatly by race/ethnicity. The prevalence of visual disabilities will increase markedly during the next 20 years, owing largely to the aging of the US population.
Similar articles
- Prevalence and Causes of Visual Impairment in a Chinese Adult Population: The Taizhou Eye Study.
Tang Y, Wang X, Wang J, Huang W, Gao Y, Luo Y, Lu Y. Tang Y, et al. Ophthalmology. 2015 Jul;122(7):1480-8. doi: 10.1016/j.ophtha.2015.03.022. Epub 2015 May 16. Ophthalmology. 2015. PMID: 25986897 - Prevalence and causes of visual impairment in The Barbados Eye Study.
Hyman L, Wu SY, Connell AM, Schachat A, Nemesure B, Hennis A, Leske MC. Hyman L, et al. Ophthalmology. 2001 Oct;108(10):1751-6. doi: 10.1016/s0161-6420(01)00590-5. Ophthalmology. 2001. PMID: 11581045 - Causes of blindness and visual impairment in urban and rural areas in Beijing: the Beijing Eye Study.
Xu L, Wang Y, Li Y, Wang Y, Cui T, Li J, Jonas JB. Xu L, et al. Ophthalmology. 2006 Jul;113(7):1134.e1-11. doi: 10.1016/j.ophtha.2006.01.035. Epub 2006 May 2. Ophthalmology. 2006. PMID: 16647133 - The Prevalence of Eye Injury in the United States, Estimates from a Meta-Analysis.
Swain T, McGwin G Jr. Swain T, et al. Ophthalmic Epidemiol. 2020 Jun;27(3):186-193. doi: 10.1080/09286586.2019.1704794. Epub 2019 Dec 17. Ophthalmic Epidemiol. 2020. PMID: 31847651 - Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study.
GBD 2019 Blindness and Vision Impairment Collaborators; Vision Loss Expert Group of the Global Burden of Disease Study. GBD 2019 Blindness and Vision Impairment Collaborators, et al. Lancet Glob Health. 2021 Feb;9(2):e144-e160. doi: 10.1016/S2214-109X(20)30489-7. Epub 2020 Dec 1. Lancet Glob Health. 2021. PMID: 33275949 Free PMC article.
Cited by
- Prognostic significance of foveal capillary drop-out and previous panretinal photocoagulation for diabetic macular oedema treated with ranibizumab.
Ebneter A, Wolf S, Zinkernagel MS. Ebneter A, et al. Br J Ophthalmol. 2016 Mar;100(3):365-70. doi: 10.1136/bjophthalmol-2014-306482. Epub 2015 Jul 17. Br J Ophthalmol. 2016. PMID: 26187951 Free PMC article. - Increasing Engagement of African American Patients with Glaucoma during Medical Encounters: Creation of a Pre-visit Video.
Sleath B, Davis SA, Carpenter DM, Robin AL, Muir KW, Lee C, Garcia N, Budenz DL. Sleath B, et al. Optom Vis Sci. 2020 Jul;97(7):503-508. doi: 10.1097/OPX.0000000000001530. Optom Vis Sci. 2020. PMID: 32697557 Free PMC article. - Comparison of Outcomes of Resident-performed Ahmed Valve Implantation vs Trabeculectomy.
Sharpe RA, Kammerdiener LL, Wannamaker KW, Fan J, Sharpe ED. Sharpe RA, et al. J Curr Glaucoma Pract. 2016 May-Aug;10(2):60-7. doi: 10.5005/jp-journals-10008-1203. Epub 2016 Aug 5. J Curr Glaucoma Pract. 2016. PMID: 27536049 Free PMC article. Review. - The Geriatric Driver: Factors That Influence When to Stop Driving.
Ikpeze TC, Elfar JC. Ikpeze TC, et al. Geriatr Orthop Surg Rehabil. 2016 Jun;7(2):106-9. doi: 10.1177/2151458516644818. Epub 2016 Apr 24. Geriatr Orthop Surg Rehabil. 2016. PMID: 27239385 Free PMC article. - Update on depression and age-related macular degeneration.
Casten RJ, Rovner BW. Casten RJ, et al. Curr Opin Ophthalmol. 2013 May;24(3):239-43. doi: 10.1097/ICU.0b013e32835f8e55. Curr Opin Ophthalmol. 2013. PMID: 23429599 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources